Risk factors for hepatitis C infection among sexually transmitted disease-infected, inner city obstetric patients

Infectious Disease in Obstetrics and Gynecology

Volumn 11, Issue 4, 2003, Pages 191-198

  Choy, Youyin ^a   Gittens Williams, Lisa ^a   Apuzzio, Joseph ^a   Skurnick, Joan ^a   Zollicoffer, Carl ^a   McGovern, Peter G ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Hepatitis C; Pregnancy; Sexually transmitted disease

Indexed keywords

ADULT; ANTIBODY DETECTION; ARTICLE; BACTERIUM CULTURE; CHLAMYDIASIS; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENT TREPONEMA ANTIBODY TEST; GONORRHEA; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; URBAN POPULATION; VENEREAL DISEASE REACTION TEST; VIRUS HEPATITIS; VIRUS INFECTION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGE DISTRIBUTION; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LOGISTIC MODELS; MASS SCREENING; MATERNAL AGE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PRENATAL CARE; PREVALENCE; PROBABILITY; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES; SOCIOECONOMIC FACTORS; URBAN POPULATION;

EID: 0345872357     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1080/10647440300025520     Document Type: Article

References (48)

1. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998;47:1-39
2. Chayama K, Kobayashi M, Tsubota A, et al. Molecular analysis of intraspousal transmission of hepatitis C virus. J Hepatol 1995;22:431-9
3. Akahane Y, Kojima M, Sugai Y, et al. Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med 1994;120:748-52
4. Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996;334:1691-6
5. Lapane KL, Jakiche AF, Sugano D, et al. Hepatitis C infection risk analysis: who should be screened? Am J Gastroenterol 1998;93:591-6
6. Hershow RC, Kalish LA, Sha B, et al. Hepatitis C virus infection in Chicago women with or at risk for HIV infection. Sex Trans Dis 1998;25:527-32
7. Brusaferro S, Barbone F, Andrian P, et al. A study on the role of the family and other risk factors in HCV transmission. Eur J Epidemiol 1999;15:125-32
8. Murphy EL, Bryzman S, Williams AE, et al. Demographic determinants of hepatitis C virus seroprevalence among blood donors. JAMA 1996;275:995-1000
9. Guadagnino V, Stroffolini T, Rapicetta M, et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997;26:1006-11
10. Alvarez-Munoz MT, Vazquez-Rosales JG, Torres-Lopez FJ, et al. Infection of pregnant women with hepatitis B and C viruses and risks for vertical transmission. Arch Med Research 1997;28:415-9
11. Leikin EL, Reinus JF, Schmell E, Tejani N. Epidemiologic predictors of hepatitis C virus infection in pregnant women. Obstet Gynecol 1994;84:529-34
12. Magriples U, Bernstein P, Snyder E, Copel JA. Can risk factor screening predict hepatitis C antibody reactivity? Am J Perinatol 1998;15:395-80
13. Lima MPJS, Pedro RJ, Rocha MDC. Prevalence and risk factors for hepatitis C virus (HCV) infection among pregnant Brazilian women. Int J Gynecol Obstet 2000;70:319-26
14. Paccagnini S, Principi N, Massironi E, et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J 1995;14:195-9
15. Zanetti AR, Tanzi E, Paccagnini S, et al. Mother-to-infant transmission of hepatitis C virus. Lancet 1995;345:289-91
16. Garland SM, Tabrizi S, Robinson P, et al. Hepatitis C - role of perinatal transmission. Aust NZJ Obstet Gynaecol 1998;38:424-7
17. Ohto H, Terazawa S, Sasaki N, et al. and the Vertical Transmission of Hepatitis C Virus Collaborative Study Group. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994;330:744-750
18. Okamoto M, Nagata I, Murakami J, et al. Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: high viral load, vaginal delivery, and negative anti-NS-4 antibody. J Infect Dis 2000;182:1511-4
19. Bonacini M, Puoti M. Hepatitis C in patients with human immunodeficiency virus infection. Arch Int Med 2000;160:3365-73
20. Flamm SL, Parker RA, Chopra S. Risk factors associated with chronic hepatitis C virus infection: limited frequency of an unidentified source of transmission. Am J Gastroenterol 1998;93:597-600
21. Delage G, Infante-Rivard C, Chiavetta JA, et al. Risk factors for acquisition of hepatitis C virus infection in blood donors: results of a case-control study. Gastroenterology 1999;116:893-9
22. Villano SA, Vlahov D, Nelson KE, et al. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol 1997;35:3274-7
23. Garfein RS, Doherty MC, Monterroso ER, et al. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acq Immune Defic Synd Hum Retrovirol 1998;18 Suppl 1:S11-19
24. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62
25. Butler TG, Dolan KA, Ferson MJ, et al. Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust 1997;166:127-30
26. Dubois F, Desenclos JC, Mariotte N, Goudeau A, and the Collaborative Study Group. Hepatitis C in a French population-based survey, 1994: sero-prevalence, frequency of viremia, genotype distribution, and risk factors. Hepatology 1997;25:1490-6
27. Lamden KH, Kennedy N, Beeching NJ, et al. Hepatitis B and hepatitis C virus infections: risk factors among drug users in northwest England. J Infection 1998;37:260-9
28. Oliveira MLA, Bastos FI, Telles PR, et al. Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil. Braz J Med Biol Res 1999;32:1107-14
29. Salleras L, Bruguera M, Vidal J, et al. Importance of sexual transmission of hepatitis C virus infection in seropositive pregnant women: a case-control study. J Med Virol 1997;52:164-7
30. Santana-Rodriguez OE, Male-Gil ML, Hernandez-Santana JF, et al. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Eur J Epidemiol 1998;14:555-61
31. Sladden TJ, Hickey AR, Dunn TM, Beard JR. Hepatitis C transmission on the north coast of New South Wales: explaining the unexplained. Med J Aust 1997;166:290-3
32. Ward C, Tudor-Williams G, Cotzias T, et al. Prevalence of hepatitis C among pregnant women attending an inner London obstetrical department: uptake and acceptability of named antenatal testing. Gut 2000;47:277-80
33. Everhart JE, Di Bisceglie AM, Murray LM, et al. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Int Med 1990;112:544-5
34. Setoguchi Y, Kajihara S, Hara T, et al. Analysis of nucleotide sequences of hepatitis C virus isolates from husband-wife pairs. J Gastroenterol Hepatol 1994;9:468-71
35. Sun CA, Chen HC, Lu CF, et al. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol 1999;59:290-6
36. Bresters D, Mauser-Bunschoten EP, Keesink HW, et al. Sexual transmission of hepatitis C virus. Lancet 1993;342:210-11
37. Semprini AE, Persico T, Thiers V, et al. Absence of hepatitis C virus and detection of hepatitis G virus/GB virus C RNA sequences in the semen of infected men. J Infect Dis 1998;177:848-54
38. Zylberberg H, Thiers V, Lagorce D, et al. Epidemiological and virological analysis of couples infected with hepatitis C virus. Gut 1999;45:112-16
39. Kumar RM, Frossad PM, Hughes PF. Sero-prevalence and mother-to-infant transmission of hepatitis C in asymptomatic Egyptian women. Eur J Obstet Gynecol Reprod Biol 1997;75:177-82
40. Fischler B, Lindh G, Lindgren S, et al. Vertical transmission of hepatitis C virus infection. Scand J Infect Dis 1996;28:353-6
41. Resti M, Azzari C, Mannelli F, et al. and the Tuscany Study Group on Hepatitis C Virus Infection in Children. Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. BMJ 1998;317:437-40
42. La Torre A, Biadaioli R, Capobianco T, et al. Vertical transmission of HCV. Acta Obstet Gynecol Scand 1998;77:889-92
43. Granovsky MO, Minkoff HL, Tess BH, et al. Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics 1998;102:355-9
44. Floreani A, Paternoster D, Zappala F, et al. Hepatitis C virus infection in pregnancy. Br J Obstet Gynaecol 1996;103:325-9
45. Tanzi M, Belleli E, Benaglia G, et al. The prevalence of HCV infection in a cohort of pregnant women, the related risk factors and the possibility of vertical transmission. Eur J Epidemiol 1997;13:517-21
46. Moriya T, Sasaki F, Mizui M, et al. Transmission of hepatitis C virus from mothers to infants: its frequency and risk factors revisited. Biomed Pharmacother 1995;49:59-64
47. Silverman NS, Jenkin BK, Wu C, et al. Hepatitis C virus in pregnancy: seroprevalence and risk factors for infection. Am J Obstet Gynecol 1993;169:583-7
48. Hillemanns P, Dannecker C, Kimmig R, Hasbargen U. Obstetrical risks and vertical transmission of hepatitis C virus infection in pregnancy. Acta Obstet Gynecol Scand 2000;79:543-7